Hot Pursuit     26-Feb-24
Suven Pharma Hyderabad facilities clear USFDA inspection
The inspection was conducted by the US Food & Drug Administration (USFDA) from 12 February 2024 to 23 February 2024.
Suven Pharmaceuticals announced that its active pharmaceutical ingredients (API) and formulations facilities (Unit-3 and Unit-5) in Pashamylaram, Hyderabad, India, have completed the pre-approval inspections (PAI) and good manufacturing practices (GMP) inspections by the US drug regyulator.

The inspection was conducted from 12 February 2024 to 23 February 2024 and no Form 483 has been issued as a result of the inspection, stated the drug maker.

Suven Pharmaceuticals is in the business of Contract Development & Manufacturing Organisation (CDMO), catering to the needs of global pharma industry.

The pharmaceutical company reported 56.60% decline in consolidated net profit to Rs 46.75 crore on 37.86% fall in revenue from operations to Rs 219.82 crore in Q3 FY24 over Q3 FY23.

The scrip rose 0.85% to currently trade at Rs 669.20 on the BSE.

Previous News
  Suven Pharmaceuticals consolidated net profit declines 56.60% in the December 2023 quarter
 ( Results - Announcements 06-Feb-24   07:34 )
  Suven Pharmaceuticals to conduct board meeting
 ( Corporate News - 15-Jun-20   17:37 )
  Suven Pharmaceuticals receives upgrade in credit ratings for bank facilities
 ( Corporate News - 25-Apr-22   14:26 )
  Suven Pharmaceuticals to discuss results
 ( Corporate News - 02-Aug-22   20:03 )
  Suven Pharmaceuticals receives credit ratings from CRISIL
 ( Corporate News - 16-Jan-23   19:30 )
  Suven Pharma appoints Himanshu Agarwal as CFO
 ( Hot Pursuit - 22-Dec-23   08:38 )
  Suven Pharmaceuticals standalone net profit rises 8.98% in the June 2023 quarter
 ( Results - Announcements 08-Aug-23   17:05 )
  Suvan Pharmaceuticals to convene board meeting
 ( Corporate News - 24-Oct-20   11:07 )
  Volumes soar at Garware Technical Fibres Ltd counter
 ( Hot Pursuit - 26-Dec-22   11:00 )
  Suven Pharmaceuticals consolidated net profit rises 12.14% in the June 2023 quarter
 ( Results - Announcements 09-Aug-23   07:43 )
  Volumes soar at Relaxo Footwears Ltd counter
 ( Hot Pursuit - 26-Dec-22   14:30 )
Other Stories
  Tata Motors JLR wholesale rises 5% YoY in Q1
  06-Jul-24   13:01
  Marico's domestic biz sees modest volume growth in Q1
  06-Jul-24   12:25
  Titan revenue rises 9% YoY, adds 61 stores in Q1
  06-Jul-24   11:09
  Dabur India expects mid to high digit revenue growth in Q1
  06-Jul-24   10:40
  Dhanlaxmi Bank gains as gross advances rises 6% YoY in Q1 FY25
  05-Jul-24   15:27
  HDFC Bank Ltd leads losers in 'A' group
  05-Jul-24   15:00
  Shilpa Medicare sizzles after Unicycive gets positive results in clinical trials of OLC
  05-Jul-24   14:52
  Manugraph India Ltd leads losers in 'B' group
  05-Jul-24   14:45
  NSE SME Nephro Care India rallies on listing day
  05-Jul-24   14:45
  ESAF SFB total deposits jumps 33% YoY in Q1
  05-Jul-24   14:43
Back Top